Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 26

1.

Mir526b and Mir655 Promote Tumour Associated Angiogenesis and Lymphangiogenesis in Breast Cancer.

Hunter S, Nault B, Ugwuagbo KC, Maiti S, Majumder M.

Cancers (Basel). 2019 Jul 4;11(7). pii: E938. doi: 10.3390/cancers11070938.

2.

Tumor suppressor role of cytoplasmic polyadenylation element binding protein 2 (CPEB2) in human mammary epithelial cells.

Tordjman J, Majumder M, Amiri M, Hasan A, Hess D, Lala PK.

BMC Cancer. 2019 Jun 11;19(1):561. doi: 10.1186/s12885-019-5771-5.

3.

Prostaglandin E2 promotes embryonic vascular development and maturation in zebrafish.

Ugwuagbo KC, Maiti S, Omar A, Hunter S, Nault B, Northam C, Majumder M.

Biol Open. 2019 Apr 18;8(4). pii: bio039768. doi: 10.1242/bio.039768.

4.

Roles of prostaglandins in tumor-associated lymphangiogenesis with special reference to breast cancer.

Lala PK, Nandi P, Majumder M.

Cancer Metastasis Rev. 2018 Sep;37(2-3):369-384. doi: 10.1007/s10555-018-9734-0. Review.

PMID:
29858743
5.

EP4 as a Therapeutic Target for Aggressive Human Breast Cancer.

Majumder M, Nandi P, Omar A, Ugwuagbo KC, Lala PK.

Int J Mol Sci. 2018 Mar 29;19(4). pii: E1019. doi: 10.3390/ijms19041019. Review.

6.

COX-2 induces oncogenic micro RNA miR655 in human breast cancer.

Majumder M, Dunn L, Liu L, Hasan A, Vincent K, Brackstone M, Hess D, Lala PK.

Sci Rep. 2018 Jan 10;8(1):327. doi: 10.1038/s41598-017-18612-3.

7.

PGE2 promotes breast cancer-associated lymphangiogenesis by activation of EP4 receptor on lymphatic endothelial cells.

Nandi P, Girish GV, Majumder M, Xin X, Tutunea-Fatan E, Lala PK.

BMC Cancer. 2017 Jan 5;17(1):11. doi: 10.1186/s12885-016-3018-2.

8.

COX-2 Induces Breast Cancer Stem Cells via EP4/PI3K/AKT/NOTCH/WNT Axis.

Majumder M, Xin X, Liu L, Tutunea-Fatan E, Rodriguez-Torres M, Vincent K, Postovit LM, Hess D, Lala PK.

Stem Cells. 2016 Sep;34(9):2290-305. doi: 10.1002/stem.2426. Epub 2016 Jun 27.

9.

Sequence and expression variations in 23 genes involved in mitochondrial and non-mitochondrial apoptotic pathways and risk of oral leukoplakia and cancer.

Datta S, Ray A, Singh R, Mondal P, Basu A, De Sarkar N, Majumder M, Maiti G, Baral A, Jha GN, Mukhopadhyay I, Panda C, Chowdhury S, Ghosh S, Roychoudhury S, Roy B.

Mitochondrion. 2015 Nov;25:28-33. doi: 10.1016/j.mito.2015.09.001. Epub 2015 Sep 21.

PMID:
26403071
10.

The role of CCL21/CCR7 chemokine axis in breast cancer-induced lymphangiogenesis.

Tutunea-Fatan E, Majumder M, Xin X, Lala PK.

Mol Cancer. 2015 Feb 10;14:35. doi: 10.1186/s12943-015-0306-4.

11.

COX-2 Elevates Oncogenic miR-526b in Breast Cancer by EP4 Activation.

Majumder M, Landman E, Liu L, Hess D, Lala PK.

Mol Cancer Res. 2015 Jun;13(6):1022-33. doi: 10.1158/1541-7786.MCR-14-0543. Epub 2015 Mar 2.

12.

D-loop somatic mutations and ∼5 kb "common" deletion in mitochondrial DNA: important molecular markers to distinguish oral precancer and cancer.

Datta S, Chattopadhyay E, Ray JG, Majumder M, Roy PD, Roy B.

Tumour Biol. 2015 Apr;36(4):3025-33. doi: 10.1007/s13277-014-2937-2. Epub 2014 Dec 20.

PMID:
25527154
13.

Prostaglandin E2 receptor EP4 as the common target on cancer cells and macrophages to abolish angiogenesis, lymphangiogenesis, metastasis, and stem-like cell functions.

Majumder M, Xin X, Liu L, Girish GV, Lala PK.

Cancer Sci. 2014 Sep;105(9):1142-51. doi: 10.1111/cas.12475. Epub 2014 Sep 11.

14.

Sacral spinal anaesthesia.

Paria R, Surroy S, Majumder M, Paria B, Paria A, Das G.

Indian J Anaesth. 2014 Jan;58(1):80-2. doi: 10.4103/0019-5049.126809. No abstract available.

15.

Single nucleotide polymorphism network: a combinatorial paradigm for risk prediction.

Das Roy P, Sengupta D, Dasgupta AK, Kundu S, Chaudhuri U, Thakur I, Guha P, Majumder M, Roy R, Roy B.

PLoS One. 2013 Sep 11;8(9):e74067. doi: 10.1371/journal.pone.0074067. eCollection 2013.

16.

A practical and sensitive method of quantitating lymphangiogenesis in vivo.

Majumder M, Xin X, Lala PK.

Lab Invest. 2013 Jul;93(7):779-91. doi: 10.1038/labinvest.2013.72. Epub 2013 May 27.

17.
18.

Differential haplotype amplification leads to misgenotyping of heterozygote as homozygote when using single nucleotide mismatch primer.

De Sarkar N, Majumder M, Roy B.

Electrophoresis. 2012 Dec;33(23):3564-73. doi: 10.1002/elps.201200363.

PMID:
23161286
19.

Targeting COX-2 and EP4 to control tumor growth, angiogenesis, lymphangiogenesis and metastasis to the lungs and lymph nodes in a breast cancer model.

Xin X, Majumder M, Girish GV, Mohindra V, Maruyama T, Lala PK.

Lab Invest. 2012 Aug;92(8):1115-28. doi: 10.1038/labinvest.2012.90. Epub 2012 May 28.

20.

Co-expression of α9β1 integrin and VEGF-D confers lymphatic metastatic ability to a human breast cancer cell line MDA-MB-468LN.

Majumder M, Tutunea-Fatan E, Xin X, Rodriguez-Torres M, Torres-Garcia J, Wiebe R, Timoshenko AV, Bhattacharjee RN, Chambers AF, Lala PK.

PLoS One. 2012;7(4):e35094. doi: 10.1371/journal.pone.0035094. Epub 2012 Apr 24.

Supplemental Content

Loading ...
Support Center